|
About us
|
How we regulate
|
Safety information
|
Committees
|
Conferences & Learning Centre |
Online services
|
Publications
|
News Centre
|
Your views
|
Main navigation 
Medicines and Healthcare products Regulatory Agency
An executive agency of the Department of Health
We enhance and safeguard the health of the public by ensuring that medicines and medical devices work and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks.
Spotlight on...
- New sections for ophthalmologists, cardiologists and orthopaedic surgeons The first sections in a new series of pages for targeted healthcare professional groups.
Quick Links
Use the drop down list to visit popular areas of the site:
Our monthly newsletter for healthcare professionals, bringing you information and clinical advice on the safe use of medicines.
Hot topics
- Better Regulation of Medicines Initiative (BROMI) MHRA-led group considering how the regulation of medicines can be adapted.
- Buying medicines over the Internet MHRA advice on the risks of buying medicines over the Internet.
- Co-proxamol Information on the painkiller, co-proxamol, which was withdrawn from the market in January 2005.
- Counterfeit medicines and medical devices How we are tackling the problem of counterfeit medicines and medical devices.
- Herbal medicines: Advice for consumers This section provides advice on using herbal medicines.
- Medicines regulatory news Our section providing the latest information about the regulation of medicines.
- Special Mail 5: Guidelines on submission of applications to the MHRA Special issue of MAIL with FAQs, defining a standard approach to sending submissions to the MHRA.
What's new
-
05 Sep 2008
Medicines Act 1968 Advisory Bodies Annual Report 2007
The Medicines Act 1968 Advisory Bodies Annual Report 2007 is now available on the website.
-
04 Sep 2008
MDA/2008/064 - Obturator - Venflon IV cannula obturator manufactured by BD
This Medical Device Alert has been issued due to a manufacturing problem which may result in cracks and holes in the packaging, which could compromise sterility.
-
03 Sep 2008
Non-medical prescribing and mixing medicines in palliative care
We have issued a statement on non-medical prescribing and mixing of medicines in palliative care.
-
03 Sep 2008
Complaints about advertising of medicines
The outcomes of the investigations into three complaints about the advertising of medicines have been published.
-
01 Sep 2008
Drug Safety Update: Volume 2, Issue 2 September 2008
The September issue of ‘Drug Safety Update’ includes: drug safety advice for fentanyl patches for chronic pain; a hot topic article on the national immunisation programme against human papillomavirus; and ‘Stop press’ information about natalizumab for multiple sclerosis.
-
01 Sep 2008
Safety information on medicines for healthcare professionals sent in August 2008
A list of letters sent to healthcare professionals in August 2008, to inform of new safety information and advice.
-
01 Sep 2008
Human papillomavirus (HPV)
A routine immunisation programme for human papillomavirus (HPV) started across the UK on 1 September 2008 for 12–13-year-old girls (school year 8). The vaccine given is called Cervarix, which protects against infection with HPV types 16 and 18.
-
29 Aug 2008
Public consultation (MLX 351): Proposals for amendments to medicines legislation to allow dispensing opticians access to certain prescription only medicines (poms)
MLX 351 seeks your views on proposals for amendments to medicines legislation to allow dispensing opticians access to certain prescription only medicines (poms).
-
26 Aug 2008
Press release: Devices regulator warns parents of faulty Baby Sleepsafe Monitors
We are asking parents and carers to check their ‘Baby Sleepsafe’ monitors, manufactured by Axminster Electronics Ltd, after concerns that the device, if ever dropped, may subsequently fail to monitor a baby’s breathing.
-
21 Aug 2008
Recent reclassifications of medicines
The maximum strength of GSL liquid paracetamol preparations for adults and children aged 12 years and over has been increased from 2.5% to 5%.
© 2008 Crown Copyright Terms and conditions Links Freedom of information Report a suspected safety problem E-mail alerting service MHRA Portal
General enquiries: 020 7084 2000 info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form.